Atlas Trials

Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance

Clinical trial NCT01237899 · COMPLETED

Trial details

NCT number
NCT01237899
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2010-10-01
Primary completion
2011-01-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.